BATS BZX Real-Time Price
As of 3:53pm ET
| +0.25 / +1.43%|
The 8 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 23.50, with a high estimate of 31.00 and a low estimate of 19.00. The median estimate represents a +32.77% increase from the last price of 17.70.
The current consensus among 9 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.